Your browser doesn't support javascript.
loading
Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study.
Chen, Yusi; Luo, Jun; Chen, Jingyuan; Kotlyar, Eugene; Li, Zilu; Chen, Wenjie; Li, Jiang.
Affiliation
  • Chen Y; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Luo J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Chen J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Kotlyar E; St. Vincent's Hospital, Sydney, NSW, Australia.
  • Li Z; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Chen W; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Li J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
Front Pharmacol ; 13: 891907, 2022.
Article in En | MEDLINE | ID: mdl-35479317
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland